Latest evidence-based view
IVOV · BUY
IVOV (Vanguard S&P Mid-Cap 400 Value) tilts toward small and mid-sized companies that are more sensitive to growth and financing. The latest month (-1.54%) conflicts with BUY, while three months (+2.78%) still support it.
IVOV currently supports a buy stance.
The latest month (-1.54%) conflicts with BUY, while three months (+2.78%) still support it.
The opposing case is clear: Higher rates and tighter credit can magnify liquidity and funding risk. The 0.10% annual expense ratio is deducted throughout ownership. The stance remains tied to the observed price trend.
Use staged sizing and reassess when the one- and three-month trends no longer support this stance.